Clinical trial

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

NCT03005184

Study summary

ClinicalTrials.gov

Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Valsartan 80 mg bid Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Enalapril 10 mg bid Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Sacubitril-Valsartan 200 mg bid Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Icatibant Normalized identity: icatibant View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2017-09-01

PhasePHASE2

Conditions

Heart Failure NYHA Class Iunresolved

Heart Failure NYHA Class IIunresolved

Heart Failure NYHA Class IIIunresolved

Interventions

Valsartan 80 mg bidDRUG

Enalapril 10 mg bidDRUG

Sacubitril-Valsartan 200 mg bidDRUG

IcatibantDRUG · verified · RxNorm: icatibant

PlaceboDRUG

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03005184 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.